MedTrace Logo

Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD

NCT02756286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 258

Last updated 2018-09-19

No results posted yet for this study

Summary

The purpose of this study is to refine a new assessment tool for Attention Deficit/Hyperactivity Disorder (ADHD) and then to test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

OTHER

NAT electroencephalography (EEG) test

Individuals in both groups are asked to perform standard behavioral tests and an electroencephalography (EEG) test.

Sponsors & Collaborators

Principal Investigators

  • Gregory V Simpson, Ph.D. · Think Now, Inc.

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-06-01
Completion
2018-07-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02756286 on ClinicalTrials.gov